UB Paderborn / Katalog / Suche / in CDI

Functional roles of the factor VIII B domain

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-11, Vol.15 (6), p.1187-1196

PIPE, S. W.

2009

Volltextzugriff (PDF)

The promise and challenges of bioengineered recombinant clotting factors

Journal of thrombosis and haemostasis, 2005-08, Vol.3 (8), p.1692-1701

PIPE, S. W.

2005

Volltextzugriff (PDF)

Bioengineered molecules for the management of haemophilia: Promise and remaining challenges

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (S6), p.68-75

Pipe, S. W.

2018

Volltextzugriff (PDF)

Advantage of recombinant von Willebrand factor for peri‐operative management in paediatric acquired von Willebrand syndrome

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (3), p.e120-e121

2018

Volltextzugriff (PDF)

Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (4), p.514-520

2016

Volltextzugriff (PDF)

Progress in the molecular biology of inherited bleeding disorders

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-07, Vol.14 (s3), p.130-137

2008

Volltextzugriff (PDF)

Strategies towards a longer acting factor VIII

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-07, Vol.12 (s3), p.42-51

2006

Volltextzugriff (PDF)

International workshop on immune tolerance induction: consensus recommendations

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-07, Vol.13 (s1), p.1-22

2007

Volltextzugriff (PDF)

Minimal dataset for post‐registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2017-09, Vol.15 (9), p.1878-1881

2017

Volltextzugriff (PDF)

Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin

Thrombosis and haemostasis, 2013-11, Vol.110 (5), p.931-939

2013

Volltextzugriff (PDF)

Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors—A retrospective analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (2), p.245-252

2018

Volltextzugriff (PDF)

Evidence-based guidelines support integrated disease management as the optimal model of haemophilia care

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (S3), p.3-5

2016

Volltextzugriff (PDF)

Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation : Evidence for nonproteolytic inactivation of factor VIIIa in vivo

Blood, 1999, Vol.93 (1), p.176-183

1999

Volltextzugriff (PDF)

Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure

Journal of thrombosis and haemostasis, 2008-07, Vol.6 (7), p.1167-1174

2008

Volltextzugriff (PDF)

Establishing the appropriate primary endpoint in haemophilia gene therapy pivotal studies

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-09, Vol.23 (5), p.643-644

2017

Volltextzugriff (PDF)

Prophylactic therapy with Fibrogammin® P is associated with a decreased incidence of bleeding episodes: a retrospective study

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-03, Vol.16 (2), p.316-321

2010

Volltextzugriff (PDF)

Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-03, Vol.12 (2), p.198-199

2006

Volltextzugriff (PDF)

Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping

Journal of thrombosis and haemostasis, 2011-06, Vol.9 (6), p.1183-1190

2011

Volltextzugriff (PDF)

The physician's role in selecting a factor replacement therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-03, Vol.12 (s1), p.21-25

PIPE, S. W.

2006

Volltextzugriff (PDF)

Radionuclide synovectomy in patients with bleeding disorders: a review of malignancy and myeloproliferative neoplasms from the ATHNdataset

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-03, Vol.23 (2), p.e160-e162

2017

Volltextzugriff (PDF)

Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-07, Vol.14 (s3), p.138-146

2008

Volltextzugriff (PDF)

The future of recombinant coagulation factors

Journal of thrombosis and haemostasis, 2003-05, Vol.1 (5), p.922-930

2003

Volltextzugriff (PDF)

Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment

Journal of thrombosis and haemostasis, 2007-05, Vol.5 (5), p.901-906

2007

Volltextzugriff (PDF)

Optimizing outcomes for patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-11, Vol.13 (s4), p.1-16

2007

Volltextzugriff (PDF)

Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.15-19

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Functional roles of the factor VIII B domain

The promise and challenges of bioengineered recombinant clotting factors

Bioengineered molecules for the management of haemophilia: Promise and remaining challenges

Advantage of recombinant von Willebrand factor for peri‐operative management in paediatric acquired von Willebrand syndrome

Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis

Progress in the molecular biology of inherited bleeding disorders

Strategies towards a longer acting factor VIII

International workshop on immune tolerance induction: consensus recommendations

Minimal dataset for post‐registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH

Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin

Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors—A retrospective analysis

Evidence-based guidelines support integrated disease management as the optimal model of haemophilia care

Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation : Evidence for nonproteolytic inactivation of factor VIIIa in vivo

Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure

Establishing the appropriate primary endpoint in haemophilia gene therapy pivotal studies

Prophylactic therapy with Fibrogammin® P is associated with a decreased incidence of bleeding episodes: a retrospective study

Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia

Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping

The physician's role in selecting a factor replacement therapy

Radionuclide synovectomy in patients with bleeding disorders: a review of malignancy and myeloproliferative neoplasms from the ATHNdataset

Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development

The future of recombinant coagulation factors

Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment

Optimizing outcomes for patients with severe haemophilia A

Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory

Suchergebnisse filtern